Skip to main content
Premium Trial:

Request an Annual Quote

UCB to Use Genedata's Software for Biologics Registration System

Premium

Genedata said this week that biopharmaceutical firm UCB will implement a biological registration system for protein-based lead candidates based on the Genedata Biologics software.

The system, called BioQuest, is expected to support UCB's research in central nervous system, autoimmune, and inflammatory disorders.

Hector Sanchez, senior director of R&D Informatics at UCB, explained that BioQuest tracks biologics molecules from early discovery to development, and gives UCB's research and development arm "central access to all relevant information on these molecules."

"Genedata Biologics provides a modular and scalable platform that supports R&D workflows in a division-of-labor environment," he said in a statement, adding that the system supports "the full process through automation, standardization, and integration."

Othmar Pfannes, CEO of Genedata, called the partnership a "major milestone" in the company's expansion into biologics R&D informatics.

"We will continue to invest significant resources to develop integrated data management and analysis solutions that increase the efficiency of a highly complex biologics R&D process," he said.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.